Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Transdermal Drug Delivery Systems Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Fentanyl
      • 1.3.3 Nitroglycerin
      • 1.3.4 Estradiol
      • 1.3.5 Nicotine
      • 1.3.6 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Transdermal Drug Delivery Systems Market Share by Application (2019-2025)
      • 1.4.2 OTC
      • 1.4.3 Rx
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Transdermal Drug Delivery Systems Market Size
      • 2.1.1 Global Transdermal Drug Delivery Systems Revenue 2014-2025
      • 2.1.2 Global Transdermal Drug Delivery Systems Sales 2014-2025
    • 2.2 Transdermal Drug Delivery Systems Growth Rate by Regions
      • 2.2.1 Global Transdermal Drug Delivery Systems Sales by Regions 2014-2019
      • 2.2.2 Global Transdermal Drug Delivery Systems Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Transdermal Drug Delivery Systems Sales by Manufacturers
      • 3.1.1 Transdermal Drug Delivery Systems Sales by Manufacturers 2014-2019
      • 3.1.2 Transdermal Drug Delivery Systems Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Transdermal Drug Delivery Systems Revenue by Manufacturers (2014-2019)
      • 3.2.2 Transdermal Drug Delivery Systems Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
    • 3.3 Transdermal Drug Delivery Systems Price by Manufacturers
    • 3.4 Key Manufacturers Transdermal Drug Delivery Systems Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Transdermal Drug Delivery Systems Market
    • 3.6 Key Manufacturers Transdermal Drug Delivery Systems Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Fentanyl Sales and Revenue (2014-2019)
      • 4.1.2 Nitroglycerin Sales and Revenue (2014-2019)
      • 4.1.3 Estradiol Sales and Revenue (2014-2019)
      • 4.1.4 Nicotine Sales and Revenue (2014-2019)
      • 4.1.5 Other Sales and Revenue (2014-2019)
    • 4.2 Global Transdermal Drug Delivery Systems Sales Market Share by Type
    • 4.3 Global Transdermal Drug Delivery Systems Revenue Market Share by Type
    • 4.4 Transdermal Drug Delivery Systems Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Transdermal Drug Delivery Systems Sales by Application

    6 United States

    • 6.1 United States Transdermal Drug Delivery Systems Breakdown Data by Company
    • 6.2 United States Transdermal Drug Delivery Systems Breakdown Data by Type
    • 6.3 United States Transdermal Drug Delivery Systems Breakdown Data by Application

    7 European Union

    • 7.1 European Union Transdermal Drug Delivery Systems Breakdown Data by Company
    • 7.2 European Union Transdermal Drug Delivery Systems Breakdown Data by Type
    • 7.3 European Union Transdermal Drug Delivery Systems Breakdown Data by Application

    8 China

    • 8.1 China Transdermal Drug Delivery Systems Breakdown Data by Company
    • 8.2 China Transdermal Drug Delivery Systems Breakdown Data by Type
    • 8.3 China Transdermal Drug Delivery Systems Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Transdermal Drug Delivery Systems Breakdown Data by Company
    • 9.2 Rest of World Transdermal Drug Delivery Systems Breakdown Data by Type
    • 9.3 Rest of World Transdermal Drug Delivery Systems Breakdown Data by Application
    • 9.4 Rest of World Transdermal Drug Delivery Systems Breakdown Data by Countries
      • 9.4.1 Rest of World Transdermal Drug Delivery Systems Sales by Countries
      • 9.4.2 Rest of World Transdermal Drug Delivery Systems Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Hisamitsu
      • 10.1.1 Hisamitsu Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.1.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.1.5 Hisamitsu Recent Development
    • 10.2 Mylan
      • 10.2.1 Mylan Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.2.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.2.5 Mylan Recent Development
    • 10.3 GSK
      • 10.3.1 GSK Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.3.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.3.5 GSK Recent Development
    • 10.4 Novartis
      • 10.4.1 Novartis Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.4.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.4.5 Novartis Recent Development
    • 10.5 Teve(Actavis)
      • 10.5.1 Teve(Actavis) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.5.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.5.5 Teve(Actavis) Recent Development
    • 10.6 Johnson & Johnson
      • 10.6.1 Johnson & Johnson Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.6.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.6.5 Johnson & Johnson Recent Development
    • 10.7 UCB
      • 10.7.1 UCB Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.7.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.7.5 UCB Recent Development
    • 10.8 Teikoku Seiyaku
      • 10.8.1 Teikoku Seiyaku Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.8.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.8.5 Teikoku Seiyaku Recent Development
    • 10.9 Bayer
      • 10.9.1 Bayer Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.9.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.9.5 Bayer Recent Development
    • 10.10 Lingrui
      • 10.10.1 Lingrui Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Transdermal Drug Delivery Systems
      • 10.10.4 Transdermal Drug Delivery Systems Product Introduction
      • 10.10.5 Lingrui Recent Development
    • 10.11 Sanofi
    • 10.12 Qizheng
    • 10.13 Endo
    • 10.14 Huarun 999
    • 10.15 Haw Par
    • 10.16 Nichiban
    • 10.17 Mentholatum Company
    • 10.18 Laboratoires Genevrier

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Transdermal Drug Delivery Systems Sales Channels
      • 11.2.2 Transdermal Drug Delivery Systems Distributors
    • 11.3 Transdermal Drug Delivery Systems Customers

    12 Market Forecast

    • 12.1 Global Transdermal Drug Delivery Systems Sales and Revenue Forecast 2019-2025
    • 12.2 Global Transdermal Drug Delivery Systems Sales Forecast by Type
    • 12.3 Global Transdermal Drug Delivery Systems Sales Forecast by Application
    • 12.4 Transdermal Drug Delivery Systems Forecast by Regions
      • 12.4.1 Global Transdermal Drug Delivery Systems Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Transdermal Drug Delivery Systems Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
      In 2019, the market size of Transdermal Drug Delivery Systems is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Transdermal Drug Delivery Systems.

      This report studies the global market size of Transdermal Drug Delivery Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Transdermal Drug Delivery Systems sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Hisamitsu
      Mylan
      GSK
      Novartis
      Teve(Actavis)
      Johnson & Johnson
      UCB
      Teikoku Seiyaku
      Bayer
      Lingrui
      Sanofi
      Qizheng
      Endo
      Huarun 999
      Haw Par
      Nichiban
      Mentholatum Company
      Laboratoires Genevrier

      Market Segment by Product Type
      Fentanyl
      Nitroglycerin
      Estradiol
      Nicotine
      Other

      Market Segment by Application
      OTC
      Rx

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Transdermal Drug Delivery Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Transdermal Drug Delivery Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Transdermal Drug Delivery Systems are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now